Lonza is expanding its commercial-scale aseptic drug product capacity in [...]

The US FDA has granted Fast Track Designation to SOTIO [...]

Novartis has agreed to acquire UK biotech Myricx Bio for [...]

Inocras and AimedBio have formed a strategic partnership to integrate [...]

Lonza will expand its highly potent active pharmaceutical ingredient manufacturing [...]

InduPro has licensed Lonza’s antibody-drug conjugate technologies to support development [...]

Lonza has entered an exclusive licensing agreement with Antharis Therapeutics [...]

AmMax Bio has licensed antibody-drug conjugate technology from Lonza to [...]

Poland-based AI drug development company Ingenix has raised €13 million [...]

SOTIO Biotech has reported positive preclinical results for SOT106, its [...]